Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells.

Transition from a sessile epithelial phenotype to a migrating mesenchymal phenotype is a crucial step in transforming growth factor-beta (TGF-beta)-induced pancreatic cancer cell migration and invasion. These profound morphologic and functional alterations are associated with characteristic changes in TGF-beta-regulated gene expression, defined by rapid repression of epithelial markers and a strong and sustained transcriptional induction of mesenchymal markers such as the intermediate filament vimentin. In this study, we have analyzed the role of the transcription factor Sp1 in TGF-beta-induced and Smad-mediated gene regulation during epithelial to mesenchymal transition (EMT) and migration of pancreatic cancer cells. Here, we show that Sp1 is required for TGF-beta-induced EMT, and that this function is especially mediated through transcriptional induction of vimentin. Our results emphasize the functional relevance of vimentin in TGF-beta-induced EMT because prevention of its induction strongly reduces cell migration. Altogether, this study helps to better understand the role of Sp1 in TGF-beta-induced progression of pancreatic cancer. It suggests that Sp1, via transcriptional induction of vimentin, cooperates with activated Smad complexes in mesenchymal transition and migration of pancreatic cancer cells upon TGF-beta stimulation.

[1]  W. Birchmeier,et al.  Epithelial-mesenchymal transitions in cancer progression. , 1996, Acta anatomica.

[2]  T. Seufferlein,et al.  Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. , 2001, Cancer research.

[3]  P. Neuhaus,et al.  Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells. , 2003, Cancer research.

[4]  R. Urrutia,et al.  Signaling disrupts mSin3A binding to the Mad1‐like Sin3‐interacting domain of TIEG2, an Sp1‐like repressor , 2002, The EMBO journal.

[5]  M. Abdelrahim,et al.  Role of Sp Proteins in Regulation of Vascular Endothelial Growth Factor Expression and Proliferation of Pancreatic Cancer Cells , 2004, Cancer Research.

[6]  P. Dijke,et al.  New insights into TGF-β–Smad signalling , 2004 .

[7]  C. Heldin,et al.  Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. , 2002, Immunology letters.

[8]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[9]  T. Gress,et al.  TGF‐β–induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase‐2 and the urokinase plasminogen activator system , 2001, International journal of cancer.

[10]  J. Black,et al.  Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancer , 2001, Journal of cellular physiology.

[11]  H. Hameister,et al.  Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells , 1999, Oncogene.

[12]  B. Wiedenmann,et al.  Activin A stimulates vascular endothelial growth factor gene transcription in human hepatocellular carcinoma cells. , 2004, Gastroenterology.

[13]  Ester Piek,et al.  Role of Transforming Growth Factor-β Signaling in Cancer , 2000 .

[14]  Jiri Zavadil,et al.  TGF-β and epithelial-to-mesenchymal transitions , 2005, Oncogene.

[15]  A. Belldegrun,et al.  Overexpression of vimentin: role in the invasive phenotype in an androgen-independent model of prostate cancer. , 2003, Cancer research.

[16]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[17]  L. Miller,et al.  An mSin3A interaction domain links the transcriptional activity of KLF11 with its role in growth regulation , 2003, The EMBO journal.

[18]  Mary J. C. Hendrix,et al.  Role of intermediate filaments in migration, invasion and metastasis , 1996, Cancer and Metastasis Reviews.

[19]  Z. Zehner,et al.  ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator, Sp1. , 2003, Nucleic acids research.

[20]  Fumiko Itoh,et al.  Signaling of transforming growth factor‐β family members through Smad proteins , 2000 .

[21]  T. Gress,et al.  TGFβ-regulated transcriptional mechanisms in cancer , 2002, International journal of gastrointestinal cancer.

[22]  Jean Paul Thiery,et al.  Epithelial-mesenchymal transitions in development and pathologies. , 2003, Current opinion in cell biology.

[23]  Takeshi Imamura,et al.  Coordinate regulation of cell growth and differentiation by TGF-β superfamily and Runx proteins , 2004, Oncogene.

[24]  T. Gress,et al.  Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells. , 2006, Carcinogenesis.

[25]  Z. Zehner,et al.  A GC-box is required for expression of the human vimentin gene. , 1999, Gene.

[26]  J. Massagué,et al.  Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.

[27]  L. Wakefield,et al.  The two faces of transforming growth factor β in carcinogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Massagué.  How cells read TGF-beta signals. , 2000, Nature reviews. Molecular cell biology.

[29]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[30]  T. Gress,et al.  KLF11 mediates a critical mechanism in TGF-beta signaling that is inactivated by Erk-MAPK in pancreatic cancer cells. , 2004, Gastroenterology.

[31]  A. Steven,et al.  The molecular biology of intermediate filaments , 1985, Cell.

[32]  D E Ingber,et al.  Cellular tensegrity: exploring how mechanical changes in the cytoskeleton regulate cell growth, migration, and tissue pattern during morphogenesis. , 1994, International review of cytology.

[33]  H. Moses,et al.  Regulation of Plasminogen Activator Inhibitor-1 Expression by Transforming Growth Factor-β-induced Physical and Functional Interactions between Smads and Sp1* , 2000, The Journal of Biological Chemistry.

[34]  Y. Kaneda,et al.  Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities. , 2000, Cancer research.

[35]  G. Seifert,et al.  Immunolocalization of the intermediate filament-associated protein plectin at focal contacts and actin stress fibers. , 1992, European journal of cell biology.

[36]  D. Ingber,et al.  Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. , 1998, Journal of cell science.

[37]  J. Massagué,et al.  How cells read TGF-β signals , 2000, Nature Reviews Molecular Cell Biology.

[38]  D. Tarin,et al.  The fallacy of epithelial mesenchymal transition in neoplasia. , 2005, Cancer research.

[39]  J. Foidart,et al.  Vimentin contributes to human mammary epithelial cell migration. , 1999, Journal of cell science.

[40]  A. Mercurio,et al.  The epithelial-mesenchymal tansition (EMT) and colorectal cancer progression , 2005, Cancer biology & therapy.

[41]  D. Tsuruta,et al.  The vimentin cytoskeleton regulates focal contact size and adhesion of endothelial cells subjected to shear stress , 2003, Journal of Cell Science.

[42]  M. Abdelrahim,et al.  Sp transcription factor family and its role in cancer. , 2005, European journal of cancer.